RFID and RTLS Location Tracking
RTLS tracking shows current equipment location using RFID or Bluetooth infrastructure, addressing the search time that consumes clinical and biomed staff hours.
Device tracking software locates equipment and traces implantable devices using RFID, barcode, and GS1 standards. Location tracking answers where equipment is now; traceability answers which device went into which patient. These are different problems with different data requirements, and systems that conflate them serve neither well.
Hospitals lose clinical time searching for equipment and lose traceability when implant records depend on manual transcription. Taction Software builds medical device tracking software covering both, with the distinction handled deliberately. Where the need is broader equipment lifecycle management, our medical equipment management software work covers that.

Our experts are ready to understand your business goals.






























































Medical device tracking software covers two related capabilities. Location tracking uses RFID, Bluetooth, or Wi-Fi positioning to show where mobile equipment currently sits, addressing search time and utilization. Traceability uses barcode and GS1 identifiers to record which specific device was used or implanted for which patient, supporting recall response and clinical documentation. Both depend on identifier standards working correctly at the point of scan. Our work sits within our broader medical devices and IoT practice.
RTLS tracking shows current equipment location using RFID or Bluetooth infrastructure, addressing the search time that consumes clinical and biomed staff hours.
GS1 standards including device identifiers enable scanning at point of use, provided the identifier data behind the barcode is accurate and complete.
Implant traceability records which device went into which patient, connecting device identifier to the clinical record for recall response.
Utilization data shows how often equipment is actually used, informing purchasing decisions that are otherwise made on assumption and request volume.
Biomed workflow links tracking to service history, since locating a device and knowing its maintenance status are usually needed together.
Connected devices extend tracking, drawing on our IoT healthcare solutions work for device connectivity patterns.
Our medical device tracking software services cover RTLS integration, scanning workflow, traceability systems, analytics, and clinical system integration. The choice that determines project success is infrastructure: RTLS accuracy depends on the physical deployment, and software cannot compensate for insufficient reader coverage. We assess that honestly before promising location precision. Engagements typically open with a review of existing infrastructure, tagging approach, and what accuracy the use case actually requires.
We integrate RTLS infrastructure where it exists and assess coverage where it does not, since location accuracy depends on physical deployment density.
Scanning workflow must be faster than the manual alternative at point of use, or staff will bypass it exactly when traceability matters most.
Traceability records link device identifiers to patients and procedures, integrating through our HL7 integration services work.
Tracking supports inventory, connecting with our hospital inventory work for par level and consumption management.
Device movement spans the supply chain, drawing on our supply chain management practice for distribution visibility.
Utilization reporting informs equipment purchasing and distribution decisions made by materials management and clinical engineering leadership.
The benefits concentrate in reduced search time, reliable traceability, and utilization visibility. Nurses and biomed technicians spend meaningful time locating equipment, and implant traceability frequently depends on manual sticker transcription that fails under procedural pressure. We publish no figures on search time, utilization, or equipment reduction, because those depend entirely on your facility layout, equipment fleet, and current practice.
Location visibility reduces the time clinical and biomed staff spend searching for mobile equipment across units and floors.
Scanned capture replaces manual transcription of implant stickers, which fails under procedural pressure exactly when accuracy matters.
Accurate traceability enables recall identification of affected patients directly, rather than manual chart review across a date range.
Utilization data informs purchasing, since fleets are frequently sized against perceived shortage that reflects location failure rather than quantity.
Linking location to service status lets biomed technicians find and service equipment without a separate search preceding every work order.
Consumption visibility supports par level decisions, complementing our medical device inventory work on stock management.
We deliver medical device tracking software projects in gated phases so clinical engineering, materials management, and IT stakeholders approve direction before engineering cost accumulates. Discovery establishes what accuracy the use case requires, since room-level and bay-level tracking demand very different infrastructure investment. Scanning workflow is tested at point of use, because a traceability step that slows a procedure gets skipped and the resulting gap is invisible until a recall.
Discovery establishes required location accuracy, since room-level and bay-level precision demand substantially different infrastructure investment.
We assess existing RTLS coverage honestly, since software cannot compensate for insufficient reader density regardless of algorithm sophistication.
Scanning is designed to be faster than manual alternatives at point of use, since traceability steps that add time are skipped under pressure.
Integration connects clinical systems for traceability capture, since device identifiers must reach the patient record to support recall response.
Deployment begins in one unit, validating accuracy and workflow before expanding infrastructure investment across a facility.
Rollout expands by unit with accuracy monitoring, tag management, and continuing support as equipment fleets and layouts change.
Device tracking software handles equipment data and, where traceability links devices to patients, PHI requiring HIPAA-aligned controls. Taction holds ISO 27001 certification. UDI identifiers under FDA rules provide the identification standard traceability depends on, and GS1 carriers are the common implementation. Where tracking software is part of a medical device or influences device function, IEC 62304 applies to that software; tracking systems used as hospital business software generally are not device software, and we assess that boundary explicitly.
Traceability linking devices to patients constitutes PHI. Our HIPAA compliance practice defines the applicable controls.
UDI identifiers carried in GS1 formats provide the identification standard, so scanning accuracy depends on manufacturer data quality upstream.
IEC 62304 governs device software. Hospital tracking systems are generally business software, and we confirm that classification rather than assuming it.
Location accuracy is bounded by physical infrastructure, so we document achievable precision rather than implying software resolves coverage gaps.
RF environment affects RTLS reliability, particularly near imaging equipment, which requires site assessment rather than assumption.
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant honesty here is about infrastructure limits. RTLS accuracy is a physical deployment property, and vendors who promise precision their client’s reader coverage cannot deliver create disappointment that gets blamed on software. Our leadership brings more than 20 years of personal experience in the field.
We document achievable precision given existing infrastructure rather than promising accuracy that reader coverage cannot physically support.
We design scanning to be faster than manual capture, since traceability steps that slow procedures get skipped when they matter most.
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow.
Our Voyant Health EHR and EMR work means traceability capture into patient records is handled by engineers with clinical systems experience.
We build manufacturer UDI systems and hospital tracking, so we understand where identifier data quality problems originate.
ISO 27001 certification means security controls are documented and auditable, supporting your vendor risk assessment efficiently.
Medical device tracking software pricing depends on scope, whether RTLS infrastructure exists, facility size, and integration breadth. Software cost is frequently smaller than the infrastructure investment RTLS requires, which we identify explicitly so budgets reflect total cost rather than software alone. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. RTLS hardware, tags, scanners, and cloud infrastructure are separate from engineering and itemized clearly.
An MVP covering barcode traceability for one service line typically runs $40,000 to $80,000 without RTLS infrastructure dependency.
A full platform with RTLS integration, traceability, inventory, and analytics typically falls between $80,000 and $200,000.
Enterprise engagements covering multi-facility tracking, full clinical integration, and utilization analytics start at $200,000.
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and infrastructure assessment with achievable accuracy documented.
RTLS infrastructure, facility size, integration count, and accuracy requirements are the largest variables, identified during discovery.
Post-launch tag management, infrastructure maintenance, and support are quoted separately as a retainer sized to facility and fleet size.
If you are evaluating medical device tracking software for equipment location, implant traceability, or utilization visibility, the fastest next step is a discovery call with our team. We will assess infrastructure, clarify which problem you are actually solving, and return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
Clinical engineering and materials leaders evaluating medical device tracking software usually ask about achievable accuracy, whether RTLS is worth the infrastructure cost, and how traceability differs from location tracking. The answers below reflect how we scope these projects.
It depends on infrastructure density, not software. Room-level accuracy is achievable with reasonable reader coverage; bay-level or bed-level precision requires substantially more. We document what your existing or planned infrastructure supports rather than quoting best-case figures from ideal deployments.
Sometimes. If your problem is search time for mobile equipment, often yes. If your problem is implant traceability, barcode scanning solves it at a fraction of the cost. We separate these because clients frequently arrive asking for RTLS when barcode addresses their actual requirement.
Traceability records which specific device was used for which patient, supporting recall response and clinical documentation. Location tracking shows where equipment is now. They use different data and solve different problems, and systems that conflate them tend to do neither well.
An MVP covering barcode traceability runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise multi-facility deployments start at $200,000. RTLS hardware and tags are separate and frequently exceed software cost.
Only if scanning is faster than the manual alternative. A traceability step that adds time to a case gets skipped, and the gap is invisible until a recall requires the record. We test scanning workflow in the actual procedural environment rather than at a desk.
Yes, where traceability data is complete. Accurate device-to-patient records let you identify affected patients directly rather than reviewing charts across a date range. Recall response quality is entirely dependent on capture discipline during the original procedure.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.